{"product_id":"glp3-r-reta","title":"GLP3-R (Retatrutide)","description":"\u003cdiv style=\"max-width:1400px;margin:0 auto;padding:20px 16px;font-family:Arial, sans-serif;line-height:1.6;color:#222;\"\u003e\n\n  \u003ch2 style=\"font-size:24px;margin-bottom:16px;\"\u003e\n    \u003cstrong\u003eGLP3-R (Retatrutide) – 10 mg [For Laboratory Research Use Only]\u003c\/strong\u003e\n  \u003c\/h2\u003e\n\n  \u003cp style=\"margin-bottom:16px;\"\u003e\n    GLP3-R (Retatrutide) is a peptide-based material supplied for controlled laboratory research applications involving multi-receptor incretin activity, metabolic regulation, and energy expenditure pathways. This material is presented for investigational use in qualified research settings only.\n  \u003c\/p\u003e\n\n  \u003cp style=\"margin-bottom:24px;\"\u003e\n    Retatrutide is a synthetic peptide commonly studied as a triple hormone receptor agonist. It is engineered to simultaneously engage the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon (GCG) receptors. In laboratory environments, it may be evaluated for receptor binding affinity, metabolic signaling responses, lipolysis activation, and other experimental endpoints relevant to preclinical research.\n  \u003c\/p\u003e\n\n  \u003ch2 style=\"font-size:20px;margin-bottom:12px;\"\u003eResearch Applications\u003c\/h2\u003e\n\n  \u003cp style=\"margin-bottom:12px;\"\u003eIn laboratory settings, researchers may study this material in connection with:\u003c\/p\u003e\n\n  \u003cul style=\"padding-left:20px;margin-bottom:24px;\"\u003e\n    \u003cli\u003eTriple-agonist receptor binding (GLP-1R, GIPR, and GCGR)\u003c\/li\u003e\n    \u003cli\u003eMetabolic regulation and energy expenditure models\u003c\/li\u003e\n    \u003cli\u003eHepatic lipid metabolism and fat reduction pathways\u003c\/li\u003e\n    \u003cli\u003eInsulin secretion and glycemic control signaling\u003c\/li\u003e\n    \u003cli\u003eAppetite regulation and satiety pathways in neurological modeling\u003c\/li\u003e\n  \u003c\/ul\u003e\n\n  \u003ch2 style=\"font-size:20px;margin-bottom:12px;\"\u003eResearch Assumptions for Laboratory Evaluation\u003c\/h2\u003e\n\n  \u003cp style=\"margin-bottom:12px;\"\u003e\n    Depending on the experimental model and protocol, laboratory researchers may evaluate:\n  \u003c\/p\u003e\n\n  \u003cul style=\"padding-left:20px;margin-bottom:24px;\"\u003e\n    \u003cli\u003eCellular signaling changes following simultaneous multi-receptor exposure\u003c\/li\u003e\n    \u003cli\u003eVariations in dose-response behavior in metabolic and physiological models\u003c\/li\u003e\n    \u003cli\u003ePeptide stability, half-life, and degradation rates\u003c\/li\u003e\n    \u003cli\u003eSynergistic effects of concurrent GIP, GLP-1, and glucagon receptor activation\u003c\/li\u003e\n    \u003cli\u003eBiochemical observations in controlled in vitro or in vivo experimental systems\u003c\/li\u003e\n  \u003c\/ul\u003e\n\n  \u003cp style=\"margin-bottom:24px;\"\u003e\n    These are research-focused areas of investigation only and do not represent product claims for consumer use.\n  \u003c\/p\u003e\n\n  \u003ch2 style=\"font-size:20px;margin-bottom:12px;\"\u003eProduct Specifications\u003c\/h2\u003e\n\n  \u003cul style=\"padding-left:20px;margin-bottom:24px;\"\u003e\n    \u003cli\u003e\n\u003cstrong\u003eResearch Reference Strength:\u003c\/strong\u003e 10 mg per vial\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003ePeptide Identification:\u003c\/strong\u003e Retatrutide (LY3437943)\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eMolecular Formula:\u003c\/strong\u003e C₂₂₃H₃₄₃N₄₆O₇₀ (approximate base structure)\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eMolecular Weight:\u003c\/strong\u003e 4731.3 g\/mol\u003c\/li\u003e\n    \u003cli\u003e\n\u003cstrong\u003eCAS Number:\u003c\/strong\u003e 2381089-83-2\u003c\/li\u003e\n  \u003c\/ul\u003e\n\n  \u003ch2 style=\"font-size:20px;margin-bottom:12px;\"\u003eMechanism of Research Interest\u003c\/h2\u003e\n\n  \u003cp style=\"margin-bottom:24px;\"\u003e\n    Experimental interest in Retatrutide focuses on its unique \"tri-agonist\" mechanism. While GLP-1 and GIP agonism are studied for their roles in insulin release and appetite suppression, the addition of glucagon receptor agonism provides a novel research pathway for investigating increased energy expenditure and direct hepatic lipid metabolism. This makes it a highly valuable compound for metabolic and cellular energy research.\n  \u003c\/p\u003e\n\n  \u003ch2 style=\"font-size:20px;margin-bottom:12px;\"\u003eResearch Use Only Notice\u003c\/h2\u003e\n\n  \u003cp style=\"margin-bottom:12px;\"\u003e\u003cstrong\u003eImportant:\u003c\/strong\u003e This product is intended strictly for laboratory research purposes only.\u003c\/p\u003e\n\n  \u003cul style=\"padding-left:20px;margin-bottom:24px;\"\u003e\n    \u003cli\u003eNot for human or animal consumption\u003c\/li\u003e\n    \u003cli\u003eNot for diagnostic, therapeutic, or clinical use\u003c\/li\u003e\n    \u003cli\u003eNot intended to prevent, treat, mitigate, or cure any disease or condition\u003c\/li\u003e\n    \u003cli\u003eTo be handled only by qualified professionals in appropriate research settings\u003c\/li\u003e\n  \u003c\/ul\u003e\n\n  \u003cp style=\"margin-bottom:16px;\"\u003e\n    This material is supplied through a third-party source. RevGenetics does not manufacture this material and does not independently verify or validate third-party descriptions, specifications, or claims beyond presenting the information supplied by that source. RevGenetics does not endorse any use outside of lawful, controlled research environments.\n  \u003c\/p\u003e\n\n  \u003cp style=\"margin-bottom:16px;\"\u003e\n    The purchaser assumes all responsibility for the safe handling, storage, and use of this material. Misuse is solely the responsibility of the purchaser. All sales of research materials are final. No refunds or returns are permitted.\n  \u003c\/p\u003e\n\n  \u003cp style=\"margin-bottom:0;\"\u003e\n    By purchasing this product, the customer acknowledges and agrees that the material is being obtained solely for lawful laboratory research use and subject to the applicable Terms and Conditions.\n  \u003c\/p\u003e\n\n\u003c\/div\u003e","brand":"Allura Health and Wellness","offers":[{"title":"10 mg (3 mL)","offer_id":45745072865417,"sku":"PL-GLP3RRETA-10MG3ML","price":240.0,"currency_code":"USD","in_stock":true},{"title":"20 mg (3 mL)","offer_id":45745072898185,"sku":"PL-GLP3RRETA-20MG3ML","price":310.0,"currency_code":"USD","in_stock":false},{"title":"30 mg (3 mL)","offer_id":45745072930953,"sku":"PL-GLP3RRETA-30MG3ML","price":410.0,"currency_code":"USD","in_stock":false},{"title":"60 mg (3 mL)","offer_id":45745072963721,"sku":"PL-GLP3RRETA-60MG3ML","price":660.0,"currency_code":"USD","in_stock":false},{"title":"100 mg (10mL)","offer_id":45745072996489,"sku":"PL-GLP3RRETA-100MG10ML","price":920.0,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/2088\/8715\/files\/vial-glp3-r-100mg-10ml-front.webp?v=1776979564","url":"https:\/\/www.revgenetics.com\/products\/glp3-r-reta","provider":"RevGenetics","version":"1.0","type":"link"}